Work Package 5 – Complex and poor prognosis cancer

Work Package 5: Complex and poor prognosis cancer

Some cancers, such as pancreatic cancer, gastric cancer and head and neck cancers, are considered as poor-prognosis cancers, due to their high mortality rates (>20 per 100,000/year) and low survival (relative survival ≤40% at 1 year, ≤30% at 3 or 5 years after diagnosis). The goal of WP5 will be to establish at least a NoE dedicated to one complex/poor prognosis cancer to increase the efficacy of treatments and quality of care, reduce inequality across the EU, boost basic/preclinical research and the use of innovative technologies, promote education, clinical practice guidelines and multidisciplinary care development, as well as epidemiological surveillance. Since some poor-prognosis cancers fall within cancers which are already covered, at least in part, by existing ERNs (namely, EURACAN), a discussion with stakeholders will be held to decide whether some poor-prognosis cancers may be added to EURACAN’s domains already in place (with regard to head & neck cancers).

The specific objectives include the definition of:

  • the scope of the NoE
  • the activities of the NoE
  • potential partners
  • governance
  • sustainability
  • indicators of efficacy and cost/efficacy
  • interplay with MSs, networks, CCCs, EU patients

Lead Beneficiary: Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie – Panstwowy Instytut Badawczy (MSCI)

WP5 6-month update (October 2022-March 2023)


  • The Framework for pilot poor prognosis Network of Expertise (NoE) was established.
  • The list of experts was created.
  • The decision by the experts group was made to base the pilot poor prognosis cancer NoE on pancreatic cancer.
  • The scope of pilot pancreatic cancer NoE was defined.


  • JANE Kick-off Meeting, 14-15 November 2022, Milan, Italy
  • JANE WP5 online meeting, 24th of January 2023, Expert discussion on the selection of the cancer type for creating a pilot network for poor prognosis cancer NoE.
  • JANE and CraNE synergy meeting
  • JANE WP5 online meeting, 30th of March 2023, Definition of the scope of NoE for pilot pancreatic cancer

Priorities for the next semester:

  • NoE Governance development
  • Identification of the endorsement criteria for pilot pancreatic cancer NoE

WP5 12-month update (October 2022-September 2023)

Register your e-mail address to receive our newsletter

* indicates required